Skip to main content
Equibles

VOLORIDGE INVESTMENT MANAGEMENT, LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1556921 JUPITER, FL
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,127,788
-$8,606,651 QoQ
Shares Held
157,429
-70.9% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#81
of 271 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $412,638,399 across 27 Biotechnology names. ARQT ranks #17 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 163,963 $102,237,489
2 IONS
Ionis Pharmaceuticals Inc
 655,454 $51,970,947
3 RARE
Ultragenyx Pharmaceutical Inc.
 1,241,556 $41,455,554
4 NTLA
Intellia Therapeutics, Inc.
 2,066,356 $34,962,743
5 EXEL
Exelixis, Inc.
 578,873 $31,496,479
6 BNTX
BioNTech SE
 243,422 $22,650,417
7 ABSI
Absci Corp
 1,602,916 $18,577,796
8 ARGX
Argenx SE
 18,797 $17,439,292

All Filings in ARQT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,127,788 157,429
2026-03-31 $12,734,439 540,511
2025-12-31 $26,543,140 914,020
2025-09-30 $15,711,286 833,490
2025-03-31 $1,204,827 77,035
2024-12-31 $4,052,766 290,938
2024-09-30 $1,194,519 128,443
2024-06-30 $5,237,490 563,171
2024-03-31 $9,349,757 943,467